How unusual is it for clinicians to buy the stock of the company they're testing for? It is not unlawful, apparently. Is it lawful but simply not 'done,' by some sort of widely observed gentlemen's agreement that it's wrong, so wrong?
This is not the same as the company paying the investigators in shares, which is what it's being made to look like. This is unaffiliated guys doing studies, and when they see what's coming out of them, deciding to buy.
I have no objection to a law prohibiting the practice, on the grounds that a conflict of interest, or even the appearance of one, must be avoided. But until it's prohibited, if I am a clinical investigator, and drawing conclusions about a procedure, and am not a buyer of the shares, it is because I don't think it's going to be a good investment.
This whole thing is odd, to me. |
